At Riverside, we put our patients’ health and well-being first. Our research team demonstrates this priority through our clinical trials by engaging in research that advances lifelong learning and evidence-based improvements in patient care. Currently, we have a range of ongoing clinical trials in Cardiology, Neurology, and Oncology. Our principal investigators have countless years of experience in study and research.
We are currently recruiting for the following clinical trials:
Cardiology
- BENEFITS OF MICROCOR (?COR™) IN AMBULATORY DECOMPENSATED HEART FAILURE (BMAD-HF)
- EMPACT-MI: A streamlined, multicentre, randomised, parallel group, double-blind placebo-controlled superiority trial to evaluate the effect of EMPAgliflozin on hospitalisation for heart failure and mortality in patients with aCuTe Myocardial Infarction
- HEART-FID - A Randomized, Double-Blind, Placebo-Controlled Study to Investigate the Efficacy and Safety of Injectafer® (Ferric Carboxymaltose) as Treatment for Heart Failure With Iron Deficiency
Oncology
- A011801 The COMPASSHER2 Residual Disease Trial A Double-Blinded, Phase III Randomized Trial of T-DM1 Compared with T-DM1 and Tucatinib
- A Survey and Registry Study of Patient Perceptions and Experiences with Oral Chemotherapy at a Community Hospital.
- An Observational Study of Triple Negative Breast Cancer at a Community Hospital
- Anal Cancer Study- EA2176: A Randomized Phase III Study of Immune Checkpoint Inhibition with Chemotherapy in Treatment-Naïve Metastatic Anal Cancer Patients.
- “Connect” The Myelodysplastic Syndromes (MDS) and Acute Myeloid Leukemia (AML) Disease Registry
- DCP-001: Use of a Clinical Tool to Address Cancer Health Disparities in the NCI Community Oncology Research Program (NCORP)
- GIANT Pancreatic Cancer Study EA2186: A Randomized Phase II Study of Gemcitabine and Nab-Paclitaxel Compared with 5-Fluorouracil, Leucovorin, and Liposomal Irinotecan in Older Patients with Treatment Naïve Metastatic Pancreatic Cancer (GIANT)
- IMPACTS PAIN management tool for Cancer Survivors_WF-1901: :Internet-delivered management of Pain Among Cancer Treatment Survivors (IMPACTS)
- OVERT Ovarian Cancer Clinical trial _AOA Dx: non-invasive blood test to assess the likelihood of ovarian malignancy
- PROACC-1 Weightloss with Cancer Study_C3651003: Study to evaluate the efficacy, safety and tolerability of ponsegromab compared to placebo in patients with cancer, cachexia, and elevated GDF 15.
Related: